Laing O’Rourke has been selected as the preferred construction partner for a cancer research hospital project in Cambridge, UK.
The company will contribute to finalising the designs and ensuring cost-effectiveness through a preconstruction services agreement, with a commitment to maximising the utilisation of contemporary construction methods.
Known as the Cambridge Cancer Research Hospital (CCRH), this initiative is a collaborative effort involving the Cambridge University Hospitals NHS Foundation Trust, the University of Cambridge, and the Cancer Research UK Cambridge Centre affiliated with the university.
The seven-storey facility will be situated within the Cambridge Biomedical Campus, and its construction is anticipated to commence in 2024. This project aligns with the government’s larger strategy of establishing 40 new hospitals by 2030.
The forthcoming hospital will encompass clinical spaces alongside three distinct research institutes, all centred around the early detection of cancer and the provision of precision treatment.
Following approval from NHS England, the Department of Health and Social Care, and the Treasury, an outline business case has been given the green light. The estimated cost of the hospital now stands at £300 million.